open access

Vol 11, No 1 (2016)
Review Papers
Published online: 2016-03-01
Get Citation

When and why do I choose triple drug combination — perindopril/indapamide/amlodipine in antihypertensive therapy?

Iwona Gorczyca-Michta, Beata Wożakowska-Kapłon
DOI: 10.5603/FC.2016.0006
·
Folia Cardiologica 2016;11(1):47-56.

open access

Vol 11, No 1 (2016)
Review Papers
Published online: 2016-03-01

Abstract

Most of the patients with hypertension require combined therapy in order to achieve target blood pressure. Antihyper­tensive agents should improve compliance with medical recommendations and allow achieving therapeutic goals. The combination of perindopril with indapamide and amlodipine is particularly recommended in population of hypertensive patients with metabolic complications because of favourable, neutral effect on blood glucose and cholesterol level. This combination has proven hypotensive effect in group of patients with difficult-to-control hypertension.

Abstract

Most of the patients with hypertension require combined therapy in order to achieve target blood pressure. Antihyper­tensive agents should improve compliance with medical recommendations and allow achieving therapeutic goals. The combination of perindopril with indapamide and amlodipine is particularly recommended in population of hypertensive patients with metabolic complications because of favourable, neutral effect on blood glucose and cholesterol level. This combination has proven hypotensive effect in group of patients with difficult-to-control hypertension.

Get Citation

Keywords

combination therapy, triple-drug combination, hypertension

About this article
Title

When and why do I choose triple drug combination — perindopril/indapamide/amlodipine in antihypertensive therapy?

Journal

Folia Cardiologica

Issue

Vol 11, No 1 (2016)

Pages

47-56

Published online

2016-03-01

DOI

10.5603/FC.2016.0006

Bibliographic record

Folia Cardiologica 2016;11(1):47-56.

Keywords

combination therapy
triple-drug combination
hypertension

Authors

Iwona Gorczyca-Michta
Beata Wożakowska-Kapłon

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl